Ultimo aggiornamento :
29/10/2024
Infostab
Elenco delle molecole
Elenchi sommari
Cerca compatibilità
Tabella di compatibilità del sito Y
Bibliografia
Le squadre di ricerca
valistab
poster
Connessioni
sponsor
Autori
Manuale d’uso
Bollettino
Spironolactone
Struttura chimica
Bibliografia : Spironolactone
tipo
pubblicazione
2435
Rivista
Allen LV, Jr, Erickson MA,
Stability of labetalol hydrochloride, metoprolol tartrate, verapamil hydrochloride, and spironolactone with hydrochlorothiazide in extemporaneously compounded oral liquids
Am J Health-Syst Pharm 1996 ; 53: 2304-2309.
2441
Rivista
Allen LV, Jr, Erickson MA,
Stability of ketoconazole, metolazone, metronidazole, procainamide hydrochloride, and spironolactone in extemporaneously compounded oral liquids
Am J Health-Syst Pharm 1996 ; 53: 2073-2078.
2489
Rivista
Mathur LK, Wickman A
Stability of extemporaneously compounded spironolactone suspensions
Am J Hosp Pharm 1989 ; 46: 2040-2042.
2534
Rivista
Nahata MC, Morosco RS, Hipple TF.
Stability of spironolactone in an extemporaneously prepared suspension at two temperatures
Ann Pharmacotherapy 1993 ;27:1198-1199.
2556
Rivista
Peterson GM, Meaney MF, Reid CA.
Stability of extemporaneously prepared mixtures of metoprolol and spironolactone.
Aust J Hosp Pharm 1989 ; 19,: 344-346.
2559
Rivista
Mc Knight DL.
The formulation of spironolactone solution for paediatric use.
Aust J Hosp Pharm 1993 ; 23: 83.
2854
Rivista
Alexander KS, Sundar S, White DB, Dollimore D.
The Formulation Development and Stability of Spironolactone Suspension
Int J Pharm Compound 1997 ; 1, 3: 195-199.
2928
Rivista
Salgado AC, Rosa ML, Duarte MA et al.
Stability of spironolactone in an extemporaneously prepared aqueous suspension: the importance of microbiological quality of compounded paediatric formulations.
EJHP Science 2005 ; 11: 68-73.
3810
Rivista
Geiger C M, Sorenson B, Whaley P.
Stability Assessment of 10 Active Pharmaceutical Ingredients Compounded in SyrSpend SF.
Int J Pharm Compound 2015 ; 19, 5 : 420-427.
4000
Rivista
Graves R, Phan K.V,Bostanian L.A,Mandal T.K, Pramar Y.V.
Stability of Spironolactone Oral Suspension in PCCA Base, SuspendIt.
Int J Pharm Compound 2017 ; 21:4 :334-338
4177
Rivista
Polonini H, Loures da Silva S, Fernandes Brandao M.A, Bauters T, De Moerloose B, De Oliveira Ferreira A.
Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF PH4.
Int J Pharm Compound 2018 ;22,6:516-526
4198
Rivista
Uriel M, Gomez-Rincon C, Marro D.
Stability of regularly prescribed oral liquids formulated with SyrSpend® SF.
Pharmazie 2018 73;196-201
4256
Rivista
Binson G, Beuzit K, Migeot V, Marco L, Troussier B, Venisse N, Dupuis A.
Preparation and Physicochemical Stability of Liquid Oral Dosage Forms Free of Potentially Harmful Excipient Designed for Pediatric Patients.
Pharmaceutics 2019 ;11,190:
Mentions Légales